NSE
Alkyl Amines Chemicals LimitedALKYLAMINE
Alkyl Amines Chemicals Limited is an Indian company engaged in the manufacturing and distribution of alkyl amines and related chemicals.
| Key products | alkyl amines, surfactants, emulsifiers |
|---|---|
| Geography | primarily operates in India with some international presence |
| Competitors | Indian Fine Chemicals, AkzoNobel India |
AI-generated overview β verify before relying on it.
Net institutional flow
No institutional deals
Institutional buyers
0 in / 0 out
High-impact filings
0 Β· tilt Neutral
Next corporate action
Dividend - Rs 10 Per Share
ex 2026-06-25
| # | Company | Inst. flow βΉCr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | MTNL | +βΉ41.3 Cr | 331 | β | β | β | β |
| 2 | ATALREAL | +βΉ7 Cr | 367 | β | β | β | β |
| 3 | GATECH | +βΉ0.4 Cr | 298 | β | β | β | β |
| 4 | ALKYLAMINEThis | +βΉ0 Cr | 4 | β | β | β | β |
| 5 | IRMENERGY | ββΉ2.2 Cr | 356 | β | β | β | β |
| 6 | QUADFUTURE | ββΉ9 Cr | 581 | β | β | β | β |
| 7 | MOBIKWIK | ββΉ150.9 Cr | 975 | β | β | β | β |
Ranked by net institutional flow (buys β sells, βΉCr). Filing momentum = bullish β bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
SWOT
Strengths
- β’ Diversified product portfolio with a focus on specialty chemicals
- β’ Strong presence in the Indian market with a large customer base
- β’ State-of-the-art manufacturing facilities and modern technology
Weaknesses
- β’ High dependence on a few key customers for revenue generation
- β’ Competition from global players like AkzoNobel India
- β’ Limited presence in international markets
Opportunities
- β’ Growing demand for specialty chemicals in the Indian pharmaceutical and cosmetic industries
- β’ Expansion into new product lines such as surfactants and emulsifiers
- β’ Increasing focus on sustainability and eco-friendly products
Threats
- β’ Fluctuations in raw material prices due to global market trends
- β’ Regulatory changes and compliance issues in the Indian chemical industry
- β’ Competition from emerging markets with lower production costs
AI-generated from our data β verify before relying on it.
- 2026-06-25ActionDividend - Rs 10 Per ShareDividend
- 2026-06-16FilingAlkyl Amines Chemicals Limited has informed the Exchange regarding Allotment of 2125 Shares.ESOP/ESOS/ESPS
- 2026-06-10FilingAlkyl Amines Chemicals Limited has informed the Exchange about Copy of Newspaper PublicationCompliance
- 2026-06-09FilingAlkyl Amines Chemicals Limited has informed the Exchange regarding 'a letter containing the exact web-link andUpdates
- 2026-06-09FilingAlkyl Amines Chemicals Limited has informed the Exchange regarding 'Business Responsibility and SustainabilityESG
- 2026-06-09FilingAlkyl Amines Chemicals Limited has informed the Exchange regarding Notice of Annual General Meeting to be heldMeeting
- 2025-06-24ActionDividend - Rs 10 Per ShareDividend
- 2025-01-09BulkBUY Β· βΉ70.5 CrGRAVITON RESEARCH CAPITAL LLP
- 2025-01-09BulkSELL Β· βΉ70.5 CrGRAVITON RESEARCH CAPITAL LLP
- 2025-01-09NetDay net ββΉ0.1 Cr
- 2024-09-18BulkSELL Β· βΉ64.6 CrGRAVITON RESEARCH CAPITAL LLP
- 2024-09-18BulkBUY Β· βΉ64.5 CrGRAVITON RESEARCH CAPITAL LLP
- 2024-09-18NetDay net ββΉ0.1 Cr
Merged from deals, filings, corporate actions and news β newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 2
- 1
- 2UpdatesNeutral
a letter containing the exact web-link and path for accessing the Annual Report for FY 2025-26 '.
Source PDF β - 2ESGNeutral
Business Responsibility and Sustainability Report for the financial year 2025-26'.
Source PDF β - 2
4 deals Β· 2024-09-18 β 2025-01-09
| Date | Counterparty | Type | Side | Value |
|---|---|---|---|---|
| 2025-01-09 | GRAVITON RESEARCH CAPITAL LLP | Prop / churn | BUY | βΉ70.5 Cr |
| 2025-01-09 | GRAVITON RESEARCH CAPITAL LLP | Prop / churn | SELL | βΉ70.5 Cr |
| 2024-09-18 | GRAVITON RESEARCH CAPITAL LLP | Prop / churn | SELL | βΉ64.6 Cr |
| 2024-09-18 | GRAVITON RESEARCH CAPITAL LLP | Prop / churn | BUY | βΉ64.5 Cr |
4 deals in the selected window β corporate actions are scoped to the same period. ~2 years of history available.
Results & transcripts
Financial results
None yet.
News & chatter on ALKYLAMINE
RSS News
0No recent news.
Google News RSS β links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.